Home > Overseas Investment News > Medical Marijuana Production Facility In Oakland Ca.
Medical Marijuana Production Facility In Oakland Ca.
2011-01-24
Brief:Cloneworks is seeking investor funds to achieve our goals in three to five years and to take stock public in five to seven years. These funds will provide for startup and expansion in other areas of production as well as new facilities across the country.

Sector: Agriculture and Forestry
Location: Oakland Ca. USA, United States
Request: Angel Funding
Deal Size: US$2,000,000

Originally, the Emerald Triangle"Unofficial Growers Association, or (UGA)"with over 100 years of combined research and field development in what is today's marijuana industry. For 30 years the UGA has provided the growing community with G1 clone stock for indoor and outdoor production. The UGA, now Cloneworks LLC (a California Corporation), has focused its interests on production of organic medically certified first generation clone stock. Cloneworks LLC is dedicated to the advancement of organic alternative medicines. All clone stock is seed grown in our engineered organic soil and backed by 30 years research in long-term single plant production, resulting in consistent quality medical grade marijuana. It is the intention of Cloneworks LLC to become the largest supplier of medical marijuana to the growing community.

In 2010 the city of Oakland passed a measure to allow licensed commercial production of medical marijuana. Medical marijuana is a thirty eight billion dollar a year industry in the US alone. Today 98% of indoor marijuana is grown from clone stock of questionable origin. With the decriminalization of medical marijuana will be new regulations and standards. To date there has been no place of origin or standard of quality that has been established in the US due to lack of legal facilities. Cloneworks, however, for 30 years has led the industry in production of quality and consistent first generation organic clone stock from its facilities in the Trinity Mountains.

Our goal is to purchase a 35,000 sq. foot indoor processing facility that will be the largest legal medical marijuana production plant in US. This proposed facility will be designed to use energy efficient LED and digital light technology cutting operating costs by over 30% annually in the first year. This facility has approximately 40,000 sq. feet of solar production area capable of producing 200kwh of electricity. Once installed, the power will be sold to the local utility company, reducing operating costs by two thirds annually. In three years this combined technology will make this the most energy efficient, modern facility of its kind in the US.

Once in full production this facility could produce 30,000 clones annually and 20,000 pounds of marijuana. This product will be sold to the 2,000 dispensaries in California as certified organic medical media produced in a licensed production facility. This is the future of government regulation for the industry with regard to interstate commerce, safety, quality and consistency of alternative organic medicine. To date 25% of the United States has already decriminalized medical marijuana making licensed production facilities possible in other states.

Estimated production/values:
Year Two:
• 6000 lbs. Medical grade marijuana/estimated market value: $18,000,000.
• 10,000 first generation organic clone stock/market value: $200,000.
Year Three:
• 12,000 lbs. medical grade marijuana/estimated market value: $36,000,000.
• 20,000 first generation clone stock/market value: $400,000.
Year Four and Five:
• 20,000 lbs. medical grade marijuana/estimated market value: $60,000,000.
• 30,000 first generation clone stock/market value: $600,000.

Cloneworks is seeking investor funds to achieve our goals in three to five years and to take stock public in five to seven years. These funds will provide for startup and expansion in other areas of production as well as new facilities across the country.


GPMN
Relevant Information